The Community Guide

- gsearch

Search Results

Narrow Results:

2023 1
2020 1

Journal Article 2

1 - 2 of 2 Results

Refine Results

Refine Results:

Biologic, Clinical, and Sociodemographic Predictors of Multi-agent Systemic Therapy for Non-Hodgkin Lymphoma in People Living with HIV: A Population-based Investigation in the State of Georgia

CITE Title : Biologic, Clinical, and Sociodemographic Predictors of Multi-agent Systemic Therapy for Non-Hodgkin Lymphoma in People Living with HIV: A Population-based Investigation in the State of Georgia Personal Author(s) : Lipscomb, Joseph;Switchenko, Jeffrey M.;Flowers, Christopher R.;Gillespie, Theresa W.;Wortley, Pascale M.;Bayakly, A. Rana;Almon, Lyn;Fernando, Robyn;Ward, Kevin C.; Published Date : 4 2020;4-2020; Source : Leuk Lymphoma. 61(4):896-904 URL : https://stacks.cdc.gov/view/cdc/86017 Lipscomb, Joseph et al. (2020). Biologic, Clinical, and Sociodemographic Predictors of Multi-agent Systemic Therapy for Non-Hodgkin Lymphoma in People Living with HIV: A Population-based Investigation in the State of Georgia. 61(4). Lipscomb, Joseph et al. "Biologic, Clinical, and Sociodemographic Predictors of Multi-agent Systemic Therapy for Non-Hodgkin Lymphoma in People Living with HIV: A Population-based Investigation in the State of Georgia" 61, no. 4 (2020) Lipscomb, Joseph et al. "Biologic, Clinical, and Sociodemographic Predictors of Multi-agent Systemic Therapy for Non-Hodgkin Lymphoma in People Living with HIV: A Population-based Investigation in the State of Georgia" vol. 61, no. 4, 2020 Export RIS Citation Information.

:

Lipscomb, Joseph ;

Switchenko, Jeffrey M.

4 2020 | Leuk Lymphoma. 61(4):896-904

:

We conducted a population-based study of biologic, clinical, and sociodemographic factors associated with receipt of multi-agent systemic therapy (MAS...
Impact of Multi-Agent Systemic Therapy on All-Cause and Disease-Specific Survival for People Living with HIV Who Are Diagnosed with Non-Hodgkin Lymphoma: Population-based Analyses from the State of Georgia

CITE Title : Impact of Multi-Agent Systemic Therapy on All-Cause and Disease-Specific Survival for People Living with HIV Who Are Diagnosed with Non-Hodgkin Lymphoma: Population-based Analyses from the State of Georgia Personal Author(s) : Lipscomb, Joseph;Switchenko, Jeffrey M.;Flowers, Christopher R.;Gillespie, Theresa W.;Wortley, Pascale M.;Bayakly, A. Rana;Almon, Lyn;Ward, Kevin C.; Published Date : 1 2023;1-2023; Source : Leuk Lymphoma. 64(1):151-160 URL : https://stacks.cdc.gov/view/cdc/140161 Lipscomb, Joseph et al. (2023). Impact of Multi-Agent Systemic Therapy on All-Cause and Disease-Specific Survival for People Living with HIV Who Are Diagnosed with Non-Hodgkin Lymphoma: Population-based Analyses from the State of Georgia. 64(1). Lipscomb, Joseph et al. "Impact of Multi-Agent Systemic Therapy on All-Cause and Disease-Specific Survival for People Living with HIV Who Are Diagnosed with Non-Hodgkin Lymphoma: Population-based Analyses from the State of Georgia" 64, no. 1 (2023) Lipscomb, Joseph et al. "Impact of Multi-Agent Systemic Therapy on All-Cause and Disease-Specific Survival for People Living with HIV Who Are Diagnosed with Non-Hodgkin Lymphoma: Population-based Analyses from the State of Georgia" vol. 64, no. 1, 2023 Export RIS Citation Information.

:

Lipscomb, Joseph ;

Switchenko, Jeffrey M.

1 2023 | Leuk Lymphoma. 64(1):151-160

:

For people living with HIV (PLWH) who are subsequently diagnosed with non-Hodgkin lymphoma (NHL), we investigate the impact of standard-of-care (SoC) ...